
Latest news from ATCC
ATCC Announces New Executive Leadership Appointments
ATCC promotes Rebecca Bradford to SVP and welcomes new executives Manoj Menon and Rupali Lach.
ATCC Appoints Dr. Ruth Cheng as New President and Chief Executive Officer
Ruth Cheng, appointed new president and CEO of ATCC, succeeds Raymond Cypess, who will remain on the Board of Directors as chairman.
ATCC Announces Award from NCI to Support Research and Vaccine Development for Cancer and HIV
NCI awarded ATCC a 5-year contract with a ceiling value of $4.06 million to provide lab services that support HIV and HTLV-1 research and vaccine development.
ATCC Announces Subaward to Advance Research for Tickborne Diseases and Vaccine Development
ATCC awarded a one-year, subaward in the amount of $165,962 from NIAID to collaborate on babesiosis and tickborne disease research.